Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Images in clinical medicine. Gynecomastia induced by prostate-cancer treatment.

Michalopoulos NV, Keshtgar MR.

N Engl J Med. 2012 Oct 11;367(15):1449. doi: 10.1056/NEJMicm1209166. No abstract available.

2.

[Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].

Abdah-Bortnyak R, Bernstein Z, Ramon N, Zalman D, Shnaider J, Kuten A.

Harefuah. 2007 Feb;146(2):126-8, 164-5. Review. Hebrew.

PMID:
17352282
3.

[Management of gynecomastia induced by bicalutamide].

Haddad E.

Ann Urol (Paris). 2006 Dec;40 Suppl 2:S49-52. Review. French.

PMID:
17361921
4.

Treatment of bicalutamide-induced breast events.

Sieber PR.

Expert Rev Anticancer Ther. 2007 Dec;7(12):1773-9. Review.

PMID:
18062751
5.

Emerging role of adjuvant hormonal therapy.

Mcleod DG.

Urology. 2002 Sep;60(3 Suppl 1):13-20; discussion 21. Review.

PMID:
12231039
6.

[Antiandrogen in prostate cancer].

Maeda O, Usami M.

Nihon Rinsho. 2002 Dec;60 Suppl 11:188-92. Review. Japanese. No abstract available.

PMID:
12599569
7.

[The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].

Sivko AV, Prokhorov AV.

Urol Nefrol (Mosk). 1997 May-Jun;(3):49-52. Review. Russian. No abstract available.

PMID:
9245060
8.

Side-effects of treatments for locally advanced prostate cancer.

O'Connor KM, Fitzpatrick JM.

BJU Int. 2006 Jan;97(1):22-8. Review. No abstract available.

9.

Maximal androgen blockade for advanced prostate cancer.

Klotz L.

Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):331-40. doi: 10.1016/j.beem.2008.01.004. Review.

PMID:
18471790
10.

Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer.

Wellington K, Keam SJ.

Drugs. 2006;66(6):837-50. Review. Erratum in: Drugs. 2006;66(15):1987.

PMID:
16706554
11.

Adjuvant hormonal treatment for prostate cancer: the bicalutamide early prostate cancer program.

Wirth MP, Froehner M.

Oncology. 2003;65 Suppl 1:1-4. Review.

PMID:
12949426
12.

Locally advanced prostate cancer treated with radiotherapy and androgen deprivation.

Kirby R.

Nat Clin Pract Urol. 2005 Jun;2(6):304-8. Review.

PMID:
16474813
13.

Use of the nonsteroidal anti-androgen Casodex in advanced prostatic carcinoma.

Kennealey GT, Furr BJ.

Urol Clin North Am. 1991 Feb;18(1):99-110. Review.

PMID:
1992575
14.

Osteoporosis during androgen deprivation therapy for prostate cancer.

Smith MR.

Urology. 2002 Sep;60(3 Suppl 1):79-85; discussion 86. Review.

PMID:
12231056
15.

Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.

Wong PW, Macris N, DiFabrizio L, Seriff NS.

Chest. 1998 Feb;113(2):548-50. Review.

PMID:
9498983
16.

Biochemical recurrence of prostate cancer.

Moul JW.

Curr Probl Cancer. 2003 Sep-Oct;27(5):243-72. Review. No abstract available.

PMID:
12963877
17.

[The role of bicalutamide in the treatment of prostate cancer].

Stav SY, Segal G.

Harefuah. 2002 Apr;141(4):379-83, 408, 407. Review. Hebrew.

PMID:
12017896
18.

Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen molecules.

Alesini D, Iacovelli R, Palazzo A, Altavilla A, Risi E, Urbano F, Manai C, Passaro A, Magri V, Cortesi E.

Oncology. 2013;84(2):92-9. doi: 10.1159/000343821. Epub 2012 Nov 2. Review.

PMID:
23128186
19.

Treatment of gynecomastia in patients with prostate cancer and androgen deprivation.

Bautista-Vidal C, Barnoiu O, García-Galisteo E, Gómez-Lechuga P, Baena-González V.

Actas Urol Esp. 2014 Jan-Feb;38(1):34-40. doi: 10.1016/j.acuro.2013.02.013. Epub 2013 Jul 11. Review. English, Spanish.

PMID:
23850393
20.

Management of gynaecomastia in patients with prostate cancer: a systematic review.

Di Lorenzo G, Autorino R, Perdonà S, De Placido S.

Lancet Oncol. 2005 Dec;6(12):972-9. Review.

PMID:
16321765
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk